
Investments
56Portfolio Exits
34Partners & Customers
10Service Providers
2About Philips
Philips (AMS: PHIA) operates as a diversified technology company. It focuses on the areas of healthcare, consumer lifestyle, and lighting. It manufactures and sells a variety of products such as diagnostic imaging systems, image-guided therapy systems, trimmers and shavers, steam irons, car lights, toothbrushes, and more. It was founded in 1891 and is based in Amsterdam, Netherlands.

Want to inform investors similar to Philips about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Philips
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Philips in 1 Expert Collection, including Conference Exhibitors.
Conference Exhibitors
6,062 items
Companies that will be exhibiting at CES 2018
Research containing Philips
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Philips in 7 CB Insights research briefs, most recently on Aug 1, 2023.

Aug 1, 2023
The state of healthcare AI in 5 charts

Dec 17, 2020
5 Ways Digital Twins Could Improve HealthcareLatest Philips News
Sep 20, 2023
Global Thrombectomy Devices Market: Competitive Landscape and Key Developments Penumbra, Inc., Stryker Corporation, Medtronic, Inc.; Edward Lifesciences Corporation, Terumo Corporation, Koninklijke Philips N.V, Teleflex Incorporated, Johnson & Johnson Services, Inc., Inari Medical, and Argon Medical among others are among the leading companies operating in the thrombectomy devices market. These players are focusing on expanding and diversifying their market presence and acquiring a novel customer base, thereby tapping prevailing business opportunities in the thrombectomy devices market. These three players dominate the global thrombectomy devices market. These companies focus on various growth strategies such as collaboration, product launches, business expansions, agreements among others to retain its position in the global market. Many market players are launching their innovative products in the thrombectomy devices market with advanced features. For instance, In February 2022, Cernuous, part of Johnson & Johnson Medical Devices Companies, launched EMBOGUARD, a next-generation balloon guide catheter that is to be used in endovascular procedures, which also includes the patients with acute ischemic stroke. In November 2021, Penumbra Inc., announced that the CHEETAH, a clinical study of its Indigo System CA RX Catheter had successfully met the primary endpoint and demonstrated high rates of blood clot removal, blood flow restoration, and myocardial perfusion in conjunction with percutaneous coronary intervention (PCI) in patients with high thrombus burden. Increasing Research and Studies in Field of Thrombectomy are Creating Development Opportunities for Global Thrombectomy Devices Market Growth During 2019-2027: There is continuous research going on in the field of thrombectomy, related to various diseases to check the success rate. Recently, in May 2019, American Heart Association (AHA) / American Sociological Association (ASA) Journals published a report on the time and relevance of clinical improvement after mechanical thrombectomy in patients with acute ischemic stroke. This study concluded that the shorter delay to clinical improvement was related to better chances of a good long-term outcome, and an improvement was >30% in National Institutes of Health Stroke Scale score at the end of mechanical thrombectomy (MT). This study represents a reliable prognostic marker for clinicians and also for clinical research. Additionally, in June 2019, American Heart Association (AHA) / American Sociological Association (ASA) Journals also published a study on the recent nationwide impact of mechanical thrombectomy on decompressive hemicraniectomy for acute ischemic stroke. This study analyzed the impact of changes in stroke management on the nationwide trends in patient characteristics, treatment modalities, and outcomes. This study showed that successful reperfusion of penumbra with mechanical thrombectomy (MT) in stroke patients leads to declining indication for decompressive hemicraniectomy (DHC) while stroke volume increases with time. Therefore, increasing research studies related to thrombectomy is increasing the market of thrombectomy devices. Order a Copy of this Report at https://www.theinsightpartners.com/buy/TIPHE100001313 Global Thrombectomy Devices Market: Segmental Overview The “Global Thrombectomy Devices Market” is segmented based on type, application, end user, and geography. Based on type, the thrombectomy devices market is segmented into mechanical thrombectomy devices, rheolytic thrombectomy devices, aspiration thrombectomy devices, and ultrasonic thrombectomy devices. In 2018, the mechanical thrombectomy devices segment held the largest share of the market. However, mechanical thrombectomy devices segment is expected to register the highest CAGR of 6.4% in the market during the forecast period Based on application, the thrombectomy devices market is segmented into neurovascular, peripheral vascular, cardiovascular and others. In 2018, cardiovascular segment held the largest share of the market. However, peripheral vascular segment is expected to grow at the fastest rate during the coming year. Based on end user, the thrombectomy devices market is segmented into hospitals & clinics, ambulatory surgical centers, and academic & research institutes. In 2018, hospitals segment held the largest share of the market. However, the hospitals segment is expected to grow at the fastest rate during the coming year. Go through further research published by The Insight Partners:
Philips Investments
56 Investments
Philips has made 56 investments. Their latest investment was in PVmed as part of their Series A - IV on December 12, 2022.

Philips Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
12/23/2022 | Series A - IV | PVmed | $14M | No | 4 | |
5/13/2022 | Corporate Minority - P2P - II | B-SOFT | $180M | Yes | 1 | |
2/23/2022 | Series A | CVAid Medical | $4M | Yes | Philips, RadBioMed, and Sanara Ventures | 5 |
8/24/2021 | Series B | |||||
8/20/2021 | Series A - II |
Date | 12/23/2022 | 5/13/2022 | 2/23/2022 | 8/24/2021 | 8/20/2021 |
---|---|---|---|---|---|
Round | Series A - IV | Corporate Minority - P2P - II | Series A | Series B | Series A - II |
Company | PVmed | B-SOFT | CVAid Medical | ||
Amount | $14M | $180M | $4M | ||
New? | No | Yes | Yes | ||
Co-Investors | Philips, RadBioMed, and Sanara Ventures | ||||
Sources | 4 | 1 | 5 |
Philips Portfolio Exits
34 Portfolio Exits
Philips has 34 portfolio exits. Their latest portfolio exit was ALung Technologies on May 05, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
5/5/2022 | Acquired | 2 | |||
3/21/2022 | Spinoff / Spinout | InnoSIGN | 2 | ||
9/30/2021 | Reverse Merger | Shapeways | 4 | ||
Date | 5/5/2022 | 3/21/2022 | 9/30/2021 | ||
---|---|---|---|---|---|
Exit | Acquired | Spinoff / Spinout | Reverse Merger | ||
Companies | InnoSIGN | Shapeways | |||
Valuation | |||||
Acquirer | |||||
Sources | 2 | 2 | 4 |
Philips Acquisitions
45 Acquisitions
Philips acquired 45 companies. Their latest acquisition was DiA Imaging Analysis on May 08, 2023.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
5/8/2023 | Series B | $19M | Acquired | 2 | ||
12/14/2021 | Series B | $52.46M | Acquired | 5 | ||
11/8/2021 | Series A | $21.4M | Acquired | 4 | ||
1/19/2021 | Growth Equity | |||||
12/18/2020 | Other Venture Capital |
Date | 5/8/2023 | 12/14/2021 | 11/8/2021 | 1/19/2021 | 12/18/2020 |
---|---|---|---|---|---|
Investment Stage | Series B | Series B | Series A | Growth Equity | Other Venture Capital |
Companies | |||||
Valuation | |||||
Total Funding | $19M | $52.46M | $21.4M | ||
Note | Acquired | Acquired | Acquired | ||
Sources | 2 | 5 | 4 |
Philips Partners & Customers
10 Partners and customers
Philips has 10 strategic partners and customers. Philips recently partnered with CoxHealth on July 7, 2023.
Date | Type | Business Partner | Country | News Snippet | Sources |
---|---|---|---|---|---|
7/27/2023 | Client | United States | CoxHealth partners with Philips for in-house virtual care solution Both Philips and CoxHealth jointly created a solution based on the close integration of Philips ' eCareManager enterprise telehealth software and Capsule Surveillance software . | 3 | |
7/19/2023 | Partner | Switzerland | `` Our partnership with the World Heart Federation aims to drive improved early detection and treatment of rheumatic heart disease , while demonstrating the sustainability and cost-effectiveness of this innovative approach in the Philippines , '' said Margot Cooijmans , Director of the Philips Foundation . | 3 | |
6/22/2023 | Licensor | Germany | Philips and BIOTRONIK Expand Care for Out-of-hospital Cardiology Labs with New Strategic Alliance `` Philips is committed to expanding access to care through its innovative solutions and BIOTRONIK 's alliance adds additional devices , including a cardiac rhythm management portfolio , to SymphonySuite , '' said Chris DeCarolis , Head of Procedural Solutions for Image Guided Therapy at Philips . | 2 | |
6/7/2023 | Client | ||||
6/2/2023 | Partner |
Date | 7/27/2023 | 7/19/2023 | 6/22/2023 | 6/7/2023 | 6/2/2023 |
---|---|---|---|---|---|
Type | Client | Partner | Licensor | Client | Partner |
Business Partner | |||||
Country | United States | Switzerland | Germany | ||
News Snippet | CoxHealth partners with Philips for in-house virtual care solution Both Philips and CoxHealth jointly created a solution based on the close integration of Philips ' eCareManager enterprise telehealth software and Capsule Surveillance software . | `` Our partnership with the World Heart Federation aims to drive improved early detection and treatment of rheumatic heart disease , while demonstrating the sustainability and cost-effectiveness of this innovative approach in the Philippines , '' said Margot Cooijmans , Director of the Philips Foundation . | Philips and BIOTRONIK Expand Care for Out-of-hospital Cardiology Labs with New Strategic Alliance `` Philips is committed to expanding access to care through its innovative solutions and BIOTRONIK 's alliance adds additional devices , including a cardiac rhythm management portfolio , to SymphonySuite , '' said Chris DeCarolis , Head of Procedural Solutions for Image Guided Therapy at Philips . | ||
Sources | 3 | 3 | 2 |
Philips Service Providers
2 Service Providers
Philips has 2 service provider relationships
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
XMS Capital Partners | Acquired Unit | Investment Bank | Financial Advisor |
Service Provider | XMS Capital Partners | |
---|---|---|
Associated Rounds | Acquired Unit | |
Provider Type | Investment Bank | |
Service Type | Financial Advisor |
Partnership data by VentureSource
Philips Team
193 Team Members
Philips has 193 team members, including current Chief Executive Officer, Neil Mesher.
Name | Work History | Title | Status |
---|---|---|---|
Neil Mesher | Chief Executive Officer | Current | |
Name | Neil Mesher | ||||
---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer | ||||
Status | Current |
Compare Philips to Competitors

Grundium develops a smart and portable scanning microscope for medical and research specialists. The company was founded in 2015 and is based in Tampere, Finland.

Aidoc operates as a healthcare technology company. It offers a Care Coordination platform that provides medical images to detect life-threatening conditions such as intracranial hemorrhage, brain aneurysm, pulmonary embolism, and more. Aidoc was founded in 2016 and is based in New York, New York.

Sectra (STO: SECTB) develops and sells IT systems and services for radiology and other image-intensive departments, orthopaedics and rheumatology.
Paige delivers artificial intelligence (AI) integrated digital diagnostics solutions and biomarkers for pathologists, oncologists, and the cancer diagnostics research and development community. It works with biopharma companies to create custom diagnostic solutions and drug development technologies to improve patient care. The company was founded in 2017 and is based in New York, New York.

Huma offers an intelligent software solution to combine predictive algorithms, artificial intelligence (AI), digital biomarkers, and data from patients. It remotely monitors patient indicators and assists researchers and pharmaceutical companies in conducting decentralized clinical trials. It combines digital biomarkers and predictive algorithms to offer a blend of medical expertise with several leading healthcare institutes. It was formerly known as Medopad. The company was founded in 2011 and is based in London, United Kingdom.

MediSafe develops a medication engagement platform. The platform helps people integrate healthier behavior into their daily lives with a cloud-synced mobile medication management system. It offers solutions, data insights, research, webinars, case studies, and more. The company is founded in 2012 and is based in Needham, Massachusetts.